Search
for
Sort by
Research 181–210 of 1000+
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
- S88 Does cone beam computed tomography decrease CTV's margins in prostate cancer radiation treatment?
- S87 Image guided radiotherapy (IGRT) in stage III prostate cancer: analysis of acute toxicity
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Effects of Mitoquinone on Doxorubicin-Induced Cytotoxicity in H9c2 Cardiac Myoblasts and 22Rv1 Prostate Cancer Cells
- Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
- Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved]
- DYS459, DYS391, DYS388 and DYS19 genetic loci have high allelic frequency in patients with prostate cancer
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- The investigation of minoxidil-induced [Ca<sup>2+</sup>]<sub>i</sub>rises and non-Ca<sup>2+</sup>-triggered cell death in PC3 human prostate cancer cells
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- A Powerful Method for Pleiotropic Analysis under Composite Null Hypothesis Identifies Novel Shared Loci Between Type 2 Diabetes and Prostate Cancer
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents
- 5α‐Reductase Isozymes and Androgen Actions in the Prostate
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Association of Spironolactone Use With Risk of Cancer
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Cancer risk by the subtype of alopecia
- Association between male pattern baldness and prostate disease: A meta-analysis
- Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa